Conditioned Medium for Autophagy Promotion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The aging process leads to decreased autophagy and proteasome activity, resulting in tissue degeneration, skin fragility, and increased inflammation, as well as various diseases associated with diminished regenerative capacity and stem cell exhaustion, for which current treatments are inadequate.
Innovation Solution
A method involving the administration of a cell culture conditioned medium (CCM) composition, produced by culturing cells under normoxic or hypoxic conditions, to promote autophagy and proteasome activation, which includes increasing the expression of specific genes and polypeptides associated with autophagy and proteasome function, potentially using nano-containers for targeted tissue delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cells are cultured under normoxic or hypoxic conditions to produce CCM composition, then autophagy and proteasome activity are enhanced, but the complexity of the culture process and delivery system increases
Solution Approach 1:
Cells are pre-cultured under controlled normoxic or hypoxic conditions to produce and accumulate autophagy-promoting factors in the CCM composition before administration. This preliminary cultivation step ensures the composition is ready to enhance autophagy and proteasome activity upon delivery, resolving the contradiction by preparing the therapeutic agent in advance under optimized conditions.
Solution Approach 2:
The CCM composition acts as an intermediary medium that transfers autophagy-promoting signals from cultured cells to target tissues. Instead of directly administering complex cell cultures, the conditioned medium serves as a simplified intermediary carrier that delivers the essential bioactive factors, reducing system complexity while maintaining therapeutic efficacy.
2Productivity
If CCM composition is administered to promote autophagy and proteasome activation, then tissue regeneration is improved, but the difficulty of targeted delivery and measurement of effectiveness increases
Solution Approach 1:
The patent utilizes changes in gene expression levels and protein activity as measurable parameters to assess CCM composition efficacy. By monitoring specific biomarkers related to autophagy and proteasome activity, the difficulty of measuring treatment effectiveness is reduced, allowing productivity improvements in tissue regeneration to be quantified through standardized parameter changes.
3Manufacturing precision
If nano-containers are used for targeted tissue delivery of CCM composition, then delivery precision is improved, but the device complexity and manufacturing difficulty increase
Solution Approach 1:
The CCM composition serves multiple functions: it delivers therapeutic factors, acts as a culture medium supernatant containing bioactive molecules, and can be formulated with or without nano-containers depending on the application. This multi-functionality allows the core composition to remain relatively simple while enabling advanced delivery options when needed, rather than requiring complex nano-container systems for all applications.
Data Source
AI summary
The present invention is directed to a methods for the promotion of autophagy and/or proteasome activation in a subject by administering a cell culture conditioned media (CCM) composition. The present invention also provides methods for reducing symptoms of aging and treating diseases or conditions including Alzheimer's disease and lung fibrosis.